Truxima 100 mg concentrate for solution for infusion clinical trials

A Phase 2 Open-label Study of Loncastuximab Tesirine in Combination with Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Patients with Diffuse Large B-cell Lymphoma (DLBCL) (LOTIS-9)

This study is testing a new combination treatment for an aggressive type of cancer called Diffuse Large B-cell Lymphoma. It's for people who haven't had treatment before and might be too frail for standard options. Researchers want to see if the new treatment is safe and effective.